Bart Delbaere
Public Communications Contact at EQT Life Sciences Group BV
Network origin in Bart Delbaere first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
KBC Securities NV
 KBC Securities NV Investment Banks/BrokersFinance KBC Securities NV is a broker/dealer firm headquartered in Brussels, Belgium. The firm was founded in 1998 and is a wholly owned subsidiary of KBC Bank NV, itself a subsidiary of KBC Groupe SA (EBR: KBC). KBC Securities provides liquidity and order execution services to institutional clients internationally, from investment banks to mutual funds and private investors.
74
| Subsidiary | Investment Banks/Brokers | 74 |
Van Lanschot Kempen NV (Broker)
 Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients.
50
| Operating Division | Investment Banks/Brokers | 50 |
EQT Life Sciences Group BV
 EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands.
22
| Subsidiary | Investment Managers | 22 |
University of Antwerp
8
| College/University | Other Consumer Services | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bart Delbaere via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
BMEYE BV
 BMEYE BV Electronic Equipment/InstrumentsElectronic Technology BMEYE BV operates as a non-invasive cardiovascular monitoring company. The firm manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices. It offers finger arterial pressure and cardiac output technologies. The company was founded in April 2005 and is headquartered in Amsterdam, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
Van Lanschot Kempen Investment Management NV
 Van Lanschot Kempen Investment Management NV Investment ManagersFinance Van Lanschot Kempen Investment Management NV (Van Lanschot Kempen) is a specialist wealth manager headquartered in Amsterdam, Netherlands. The firm was founded in 1991 and was formerly known as Kempen Capital Management NV. They are a wholly-owned subsidiary of Van Lanschot Kempen NV (AMS: VLK). Van Lanschot Kempen administers Dutch pension funds and provides integral asset management for Dutch institutional clients. | Investment Managers | Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities | |
| BANK MILLENNIUM S.A. | Regional Banks | Director/Board Member | |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Founder Private Equity Analyst Private Equity Investor Private Equity Investor Investment Committee Member Private Equity Investor Private Equity Investor Private Equity Investor Director of Finance/CFO Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Investor General Counsel Private Equity Analyst | |
| CYFROWY POLSAT S.A. | Cable/Satellite TV | Director/Board Member | |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree | |
| ZE PAK SA | Electric Utilities | Director/Board Member | |
KBC TFI SA
 KBC TFI SA Investment ManagersFinance KBC TFI SA is the investment management subsidiary of PKO BP Finat Sp Zoo, which is owned by Powszechna Kasa Oszczednosci Bank Polski (WSE: PKO) in Poland. The firm was founded in 2005 when TFI Kredyt Bank SA acquired Warta TFI SA and Warta Asset Management SA. Headquartered in Warsaw, KBC TFI provides asset management services and manages a range of funds across various strategies and asset classes to private individuals, corporate clients and institutions. | Investment Managers | Director/Board Member | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Corporate Officer/Principal | |
| University of Twente | College/University | Corporate Officer/Principal Graduate Degree | |
| NEXSTIM PLC | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| University of Amsterdam | College/University | Undergraduate Degree Doctorate Degree | |
| Erasmus University Rotterdam | College/University | Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| University of Leiden | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| University of Utrecht | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Kempen & Co. USA, Inc.
 Kempen & Co. USA, Inc. Investment Banks/BrokersFinance Founded in 1995, Kempen & Co., USA, Inc. is an SEC-registered broker/dealer located in New York City. The firm is a wholly-owned 100% subsidiary of Kempen & Co. NA, an Amsterdam-based merchant bank that was founded in 1903. Kempen & Co. USA focuses on Benelux equities (home-market), European real estate equities, European clean Technology and biotechnology equities. The firm's research includes equity and property reports, daily comments, technical analysis, strategic overviews and complete sector reports. Kempen & Co. USA provides services to institutional clients. The firm is a member of FINRA. | Investment Banks/Brokers | Analyst-Equity Sales & Marketing | |
| Vrije Universiteit Amsterdam | College/University | Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| Ghent University | College/University | Corporate Officer/Principal Graduate Degree | |
| Katholieke Universiteit Leuven | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| Vlerick Leuven Gent Management School | College/University | Graduate Degree Graduate Degree | |
ING Bank NV (Broker)
 ING Bank NV (Broker) Investment Banks/BrokersFinance ING Bank NV (Broker) (ING Bank-Broker) is the broker-dealer division of ING Bank NV, an investment bank headquartered in Amsterdam, Netherlands. It is a wholly-owned subsidiary of ING Groep N.V. (AMS: INGA; NYSE: ING), a Dutch multinational banking and financial services corporation. The firm was founded in 1991 through the merger of Nationale-Nederlanden and NMB Postbank Groep. ING Bank-Broker provides brokerage services to institutions, large corporations, and medium-sized companies. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Chairman Director/Board Member | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
EuroLOT SA
 EuroLOT SA AirlinesTransportation EuroLOT SA engages in the provision of domestic and international air transportation services. The company was founded on December 19, 1996 and is headquartered in Warsaw, Poland. | Airlines | Chairman | |
| CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member Corporate Officer/Principal | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
McKinsey & Co., Inc. (Belgium)
 McKinsey & Co., Inc. (Belgium) Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consultancy services. It serves businesses, governments, non governmental organizations, and non-profit organizations. The company was founded by James O. McKinsey in 1926 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Tradition Securities & Futures SA
 Tradition Securities & Futures SA Investment Banks/BrokersFinance Tradition Securities & Futures SA provides brokerage services. It offers certificates of deposit, commercial paper, short-term, short, medium, long term state, non-government, convertible bonds and structured products. The firm was founded in 1959 and is headquartered in Paris, France. | Investment Banks/Brokers | Analyst-Equity | |
PZU SA
 PZU SA Property/Casualty InsuranceFinance Part of Powszechny Zaklad Ubezpieczen SA, PZU SA is the biggest financial institution in Central and Eastern Europe. The company is based in Warsaw, Poland, and its subsidiaries play an important role in markets in Ukraine, Lithuania, and Latvia. PZU has been listed on the Warsaw Stock Exchange since 2010 and is one of the large cap blue chips offering the highest amount of liquidity from its floatation. The Polish company's traditions date back to 1803, when the first insurance company was established in Poland. The PZU Group has consolidated assets totaling 90 billion euros and serves 22 million clients in five countries, offering products and services to retail clients, small and medium enterprises, and business entities. The CEO of the company is Beata Kozlowska-Chyla. | Property/Casualty Insurance | Director/Board Member | |
Neuravi Ltd.
 Neuravi Ltd. Medical SpecialtiesHealth Technology Neuravi Ltd. designs and develops medical devices for the treatment of acute stroke. Through its investment in the Neuravi Thromboembolic Initiative the company supports collaboration between engineers, clinicians and researchers to deepen the understanding of clot and occlusion dynamics to improve patient outcomes in stroke. Neuravi The company was founded by Mahmood K. Razav, Eamon Brady, John O'Shaughnessy and David Vale in 2009 and is headquartered in Galway, Ireland. | Medical Specialties | Director/Board Member Director/Board Member | |
LSP Advisory BV
 LSP Advisory BV Investment ManagersFinance Part of LSP Advisory Group BV, EQT Life Sciences is a healthcare investment firm based in Amsterdam, Netherlands. EQT Life Sciences has been connecting investors to inventors in the healthcare sector for over 30 years. The Dutch company has invested in close to two hundred private companies, raising billions of additional capital directed at supporting their R & D. EQT Life Sciences believes in fostering life and constant innovation in healthcare to achieve that goal. The company was founded in 1998, and Mark A. Wegter has been the CEO since then. Recently, EQT Life Sciences was acquired by EQT AB, one of the largest private equity firms in Europe, and among the top-ten private equity firms globally. | Investment Managers | Director/Board Member Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
ViCentra BV
 ViCentra BV Electronic Equipment/InstrumentsElectronic Technology ViCentra BV engages in the development of medical devices. It focuses in creating devices for diabetes patients. The company was founded by Tim Oakes and Joseph John Cefai in 2013 and is headquartered in Utrecht, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| University of Warsaw Faculty of Management | College/University | Corporate Officer/Principal | |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
| Teraz Polska Foundation | Corporate Officer/Principal | ||
European Studies Association
 European Studies Association Miscellaneous Commercial ServicesCommercial Services The European Studies Association, also known as the European Union Studies Association (EUSA), is a professional and scholarly association that focuses on the European Union. The association's main objective is to promote research and education on the European Union, and it is considered the premier organization in this field. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
Egle Therapeutics SAS
 Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Health Economics Privak II NV
 Health Economics Privak II NV Finance/Rental/LeasingFinance Health Economics Privak II NV is a Belgian company that provides credit intermediation services. The private company is based in De Pinte, Belgium. The company was founded in 2017. | Finance/Rental/Leasing | Director/Board Member Director/Board Member | |
| OCULIS HOLDING AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
| Netherlands | 20 |
| Belgium | 11 |
| Poland | 10 |
| United States | 4 |
| France | 3 |
Sectoral
| Finance | 16 |
| Consumer Services | 15 |
| Health Technology | 14 |
| Commercial Services | 4 |
| Electronic Technology | 3 |
Operational
| Director/Board Member | 163 |
| Analyst-Equity | 85 |
| Private Equity Investor | 41 |
| Corporate Officer/Principal | 37 |
| Graduate Degree | 24 |
Most connected contacts
| Insiders | |
|---|---|
| Martijn Kleijwegt | 33 |
| René Kuijten | 30 |
| Rudy Dekeyser | 29 |
| Alojzy Zbigniew Nowak | 26 |
| John Paul de Koning | 21 |
| Anne Portwich | 16 |
| Vincent Brichard | 15 |
| Bruno Luc Myriam Holthof | 14 |
| Clemens A. van Blitterswijk | 12 |
| Mark Wegter | 11 |
| Jacques Humbert | 10 |
| Cillian King | 9 |
| Felice Verduyn-van Weegen | 9 |
| Tycho Sneyers | 9 |
| Marco Miserez | 8 |
- Stock Market
- Insiders
- Bart Delbaere
- Company connections
